Cargando…

Harnessing DLL3 inhibition: From old promises to new therapeutic horizons

Small-cell lung cancer (SCLC) is an aggressive neuroendocrine tumor with a high relapse rate, limited therapeutic options, and poor prognosis. The combination of chemotherapy and immune-checkpoint inhibitors brings a new therapeutic era, although the lack of predictive biomarkers of response reduces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortinovis, Diego Luigi, Colonese, Francesca, Abbate, Maria Ida, Sala, Luca, Meazza Prina, Marco, Cordani, Nicoletta, Sala, Elisa, Canova, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751403/ https://www.ncbi.nlm.nih.gov/pubmed/36530878 http://dx.doi.org/10.3389/fmed.2022.989405

Ejemplares similares

Novel Therapeutic Options for Small Cell Lung Cancer
por: Canova, Stefania, et al.
Publicado: (2023)

Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
por: Putzu, Carlo, et al.
Publicado: (2023)

Focus on Nivolumab in NSCLC
por: Cortinovis, Diego L., et al.
Publicado: (2016)

An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective
por: Cordani, Nicoletta, et al.
Publicado: (2023)

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma
por: Cortinovis, Diego, et al.
Publicado: (2021)

Harnessing Minimal Residual Disease as a Predictor for Colorectal Cancer: Promising Horizons Amidst Challenges
por: Wen, Xiaofen, et al.
Publicado: (2023)

Therapeutic promise and challenges of targeting DLL4/NOTCH1
por: Yan, Minhong
Publicado: (2011)

Targeted therapies and immunotherapy in non-small-cell lung cancer
por: Cortinovis, D, et al.
Publicado: (2016)

Translational Horizons in the Tumor Microenvironment: Harnessing Breakthroughs and Targeting Cures
por: Sun, Yu
Publicado: (2015)

Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review
por: Cortinovis, Diego, et al.
Publicado: (2021)

Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
por: Geffers, Insa, et al.
Publicado: (2007)

Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo
por: Preuße, Kristina, et al.
Publicado: (2015)

Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine
por: Shimizu, Hiromichi, et al.
Publicado: (2014)

Design of two immunotoxins based rovalpituzumab antibody against DLL3 receptor; a promising potential opportunity
por: Ataee, Mohammad Hossein, et al.
Publicado: (2022)

On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
por: Cole, Michael A., et al.
Publicado: (2020)

Closer and closer? Maternal immunization: current promise, future horizons
por: Engmann, Cyril, et al.
Publicado: (2020)

Normal Development in Mice Over-Expressing the Intracellular Domain of DLL1 Argues against Reverse Signaling by DLL1 In Vivo
por: Redeker, Christian, et al.
Publicado: (2013)

The ectodomains determine ligand function in vivo and selectivity of DLL1 and DLL4 toward NOTCH1 and NOTCH2 in vitro
por: Tveriakhina, Lena, et al.
Publicado: (2018)

Old problems and new horizons in world physics
por: Krasnoholovets, Volodymyr
Publicado: (2019)

New Horizons for Probucol, an Old, Mysterious Drug
por: Yamashita, Shizuya, et al.
Publicado: (2021)

Molecular mapping of a sunflower rust resistance gene from HAR6
por: Bulos, Mariano, et al.
Publicado: (2013)

Sneaky Diagnosis of Pleural Malignant Mesothelioma in Thoracic Surgery: All That Glitters Is Not Gold
por: Orlandi, Riccardo, et al.
Publicado: (2022)

Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon
por: Elsouri, Kawther N, et al.
Publicado: (2022)

Harnessing the Power and Promise of Human Rights to End AIDS by 2030
por: Sidibé, Michel
Publicado: (2017)

Harnessing Immune Response to Malignant Lung Nodules. Promise and Challenges
por: Taguchi, Ayumu, et al.
Publicado: (2019)

Harnessing the Potential of Stem Cells for Disease Modeling: Progress and Promises
por: Argentati, Chiara, et al.
Publicado: (2020)

Clinical implications of DLL4 expression in gastric cancer
por: Ishigami, Sumiya, et al.
Publicado: (2013)

DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
por: Yao, James, et al.
Publicado: (2022)

Emerging Concepts Promising New Horizons for Marine Biodiscovery and Synthetic Biology
por: Reen, F. Jerry, et al.
Publicado: (2015)

Vitamin D: Promises on the Horizon and Challenges Ahead for Fighting Pancreatic Cancer
por: Wei, Daoyan, et al.
Publicado: (2021)

Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment
por: Cordani, Marco, et al.
Publicado: (2018)

Expanding Your Horizon 2017
por: Knapper, Ines, et al.
Publicado: (2017)

Expanding Your Horizon 2019
por: Adam Bourdarios, Claire, et al.
Publicado: (2019)

Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
por: Clemens, E. Bridie, et al.
Publicado: (2018)

From Panic to Promise: Harnessing Medical Student Leadership in COVID-19
por: Raikhel, A. Vincent, et al.
Publicado: (2022)

Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology
por: Reinherz, Ellis L., et al.
Publicado: (2023)

A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization
por: Mattoo, Sameer-ul-Salam, et al.
Publicado: (2021)

DLL3: an emerging target in small cell lung cancer
por: Owen, Dwight H., et al.
Publicado: (2019)

Maintenance of Bone Homeostasis by DLL1‐Mediated Notch Signaling
por: Muguruma, Yukari, et al.
Publicado: (2017)

Dll1 haploinsufficiency causes brain abnormalities with functional relevance
por: Arzate, Dulce-María, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kvhnjvvmiimodogli4846s1a41